- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT04435080
Physical Rehabilitation in ICU in ARDS Patients With COVID-19
Physical Rehabilitation in Intensive Care Unit in Acute Respiratory Distress Syndrome Patients With COVID-19
The primary aim of this study is to evaluate the effect of physical rehabilitation performed in intensive care unit on the range of joint motions and muscle strength of survivors following discharge from intensive care unit in patients with COVID-19. Secondary outcome is to assess the duration of mechanical ventilation, length of stay in intensive care unit and in hospital, and mortality rates during intensive care unit stay and health related quality of life following discharge in survivors.
Until April 14 patients were provided all the intensive care managements except for rehabilitation and patients discharged before this time constituted the 'non-rehabilitation' group (n=17). Patients discharged after April 14 were provided rehabilitation in addition to usual intensive care unit care and constituted the study 'rehabilitation' group (n=18).
Passive range of motion exercises to each joint and neuromuscular electrical stimulation to bilateral quadriceps and tibialis anterior muscles were applied 6 days/week in the 'rehabilitation' group during intensive care unit stay.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
Patients with acute respiratory distress syndrome could develop muscle weakness associated with impairment of physical function defined as intensive care unit acquired weakness. Early rehabilitation is recommended to prevent complications including muscle weakness and joint contractures, enhance weaning from mechanical ventilation, improve outcome, quality of life.
COVID-19 is an acute infection with a high risk of enormous cytokine storm exacerbating the clinical condition in acute respiratory distress syndrome and is thought to further increase the risk of muscle weakness.
Study participants were recruited among patients hospitalized in the intensive care unit at Koc University Hospital. Standard care for these patients consisted of respiratory support, intravenous fluid therapy, medical treatment including anticoagulation and sedation, nutrition, change of position every 4 hours, and if needed, hemodynamic support. The non-rehabilitation group patients discharged before April 14, 2020, were provided with this standard care. The rehabilitation group patients that discharged after April 14, 2020, were provided rehabilitation in addition to usual standard care. The rehabilitation program consisted of a passive range of motion exercises for each joint of the extremities for 15 minutes/day, 6 days/week, and neuromuscular electrical stimulation to bilateral quadriceps and tibialis anterior muscles for 52 minutes/day, 6 days/week. The physiatrists evaluated the patients. Exercises and electrical stimulation were applied daily by physiotherapists. The physiatrist and anesthesiologist discussed the clinical status of the patients daily and the physiatrist modified the rehabilitation program, if needed. Patients were enrolled in the rehabilitation program if there is hemodynamical stability.
Information regarding demographic and clinical features, medications used, duration of mechanical ventilation, length of stay in the intensive care unit and hospital, and mortality were obtained from the digital patient records in both groups.
Following discharge, patients were evaluated for range of joint motion, manual muscle strength test, hand grip strength and Short form-36.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Istanbul, Turkki, 34010
- Koç University School of Medicine
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- Diagnosis of acute respiratory distress syndrome secondary to COVID-19
- Hospitalised in intensive care unit
- Age older than 18 years
Exclusion Criteria:
- Acute respiratory distress syndrome due to other pathogens or causes
- Younger than 18 years
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
|---|
|
Non-rehabilitation
The patients hospitalised in ICU who were provided all the intensive care managements except for rehabilitation interventions (discharged from intensive care unit before April 14, 2020)
|
|
Rehabilitation
The patients hospitalised in ICU who were provided rehabilitation interventions in addition to all the intensive care managements.
(discharged from intensive care unit after April 14, 2020)
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Hand grip strength
Aikaikkuna: 1 month after discharge from hospital
|
Hand grip strength is an indicator of overall muscle strength that predicts mortality in older patients.
Handgrip strength was measured using a handheld dynamometer according to the instructions of the American Society of Hand Therapists.Patients were seated placing their arms by their sides with the elbow flexed to 90°, the forearm mid-prone, and the wrist in neutral position.
Patients were asked to grip the dynamometer with maximal effort using standard verbal encouragement.
Three trials were performed in the dominant hand with a 30 sec rest between trials and the highest value was recorded in kg.
The cut-off values of grip strength is 28.6 kg in men and 16.4 kg in women.
The measurement was performed 1 month after discharge.
|
1 month after discharge from hospital
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Short form - 36
Aikaikkuna: 1 month after discharge from hospital
|
Short form - 36 measures health related quality of life.
It is a self-reported survey that evaluates individual health status with eight parameters consisting of physical function, pain, role limitations attributed to physical problems, role limitations attributed to emotional problems, mental health, social functioning, energy/ vitality, general health perception.
There is not a summary score, each section is scored between 0-100, 0 indicates the worst condition, 100 indicates the best.
The measurement was performed 1 month after discharge.
|
1 month after discharge from hospital
|
|
Length of stay in intensive care unit
Aikaikkuna: through study completion, an average of 3 months
|
Number of days of stay in intensive care unit from admission to discharge
|
through study completion, an average of 3 months
|
|
Length of stay in hospital
Aikaikkuna: through study completion, an average of 3 months
|
Number of days of stay in hospital from admission to hospital to discharge from hospital
|
through study completion, an average of 3 months
|
|
Duration of invasive mechanical ventilation
Aikaikkuna: through study completion, an average of 3 months
|
Number of days of invasive mechanical ventilation during intensive care unit
|
through study completion, an average of 3 months
|
|
Manual muscle strength
Aikaikkuna: 1 month after discharge from hospital
|
Manual muscle strength was graded via a composite of Medical Research Council Scale score which has an excellent inter-rater reliability in survivors of critical illness.
This scale range from 0 point (no muscle contraction) to 5 points (normal muscle strength).
Through examination of 3 muscle groups in each limb (arm abduction, forearm flexion, wrist extension, hip flexion, knee extension and ankle dorsiflexion), clinical important muscle weakness has been defined as a composite score < 48 out of maximum 60 points.
The measurement was performed 1 month after discharge.
|
1 month after discharge from hospital
|
|
Range of joint motion
Aikaikkuna: 1 month after discharge from hospital
|
Range of joint motion was evaluated in upper and lower extremity joints by physical examination and the results were recorded as normal or restricted for each joint.
The measurement was performed 1 month after discharge.
|
1 month after discharge from hospital
|
Yhteistyökumppanit ja tutkijat
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Turan Z, Ozyemisci Taskiran O, Erden Z, Kokturk N, Kaymak Karatas G. Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study. Turk J Med Sci. 2019 Jun 18;49(3):802-808. doi: 10.3906/sag-1811-22.
- Yoo JI, Choi H, Ha YC. Mean Hand Grip Strength and Cut-off Value for Sarcopenia in Korean Adults Using KNHANES VI. J Korean Med Sci. 2017 May;32(5):868-872. doi: 10.3346/jkms.2017.32.5.868.
- Dodoo-Schittko F, Brandstetter S, Blecha S, Thomann-Hackner K, Brandl M, Knuttel H, Bein T, Apfelbacher C. Determinants of Quality of Life and Return to Work Following Acute Respiratory Distress Syndrome. Dtsch Arztebl Int. 2017 Feb 17;114(7):103-109. doi: 10.3238/arztebl.2017.0103.
- Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr. 2004 Apr;23(2):273-80. doi: 10.1016/S0261-5614(03)00129-8.
- Clavet H, Hebert PC, Fergusson D, Doucette S, Trudel G. Joint contracture following prolonged stay in the intensive care unit. CMAJ. 2008 Mar 11;178(6):691-7. doi: 10.1503/cmaj.071056.
- Sosnowski K, Lin F, Mitchell ML, White H. Early rehabilitation in the intensive care unit: an integrative literature review. Aust Crit Care. 2015 Nov;28(4):216-25. doi: 10.1016/j.aucc.2015.05.002. Epub 2015 Jul 2.
- Connolly B, O'Neill B, Salisbury L, Blackwood B; Enhanced Recovery After Critical Illness Programme Group. Physical rehabilitation interventions for adult patients during critical illness: an overview of systematic reviews. Thorax. 2016 Oct;71(10):881-90. doi: 10.1136/thoraxjnl-2015-208273. Epub 2016 May 24.
- Walsh CJ, Batt J, Herridge MS, Dos Santos CC. Muscle wasting and early mobilization in acute respiratory distress syndrome. Clin Chest Med. 2014 Dec;35(4):811-26. doi: 10.1016/j.ccm.2014.08.016. Epub 2014 Sep 30.
- Akar O, Gunay E, Sarinc Ulasli S, Ulasli AM, Kacar E, Sariaydin M, Solak O, Celik S, Unlu M. Efficacy of neuromuscular electrical stimulation in patients with COPD followed in intensive care unit. Clin Respir J. 2017 Nov;11(6):743-750. doi: 10.1111/crj.12411. Epub 2015 Dec 16.
- Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve. 1991 Nov;14(11):1103-9. doi: 10.1002/mus.880141111.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
- Patologiset prosessit
- Koronavirusinfektiot
- Coronaviridae-infektiot
- Nidovirales-infektiot
- RNA-virusinfektiot
- Virussairaudet
- Infektiot
- Hengitysteiden infektiot
- Hengityselinten sairaudet
- Hengityshäiriöt
- Keuhkokuume, virus
- Keuhkokuume
- Keuhkosairaudet
- Sairauden ominaisuudet
- Sairaus
- Vauva, vastasyntynyt, sairaudet
- Keuhkovaurio
- Vauva, Keskoset, Sairaudet
- COVID-19
- Oireyhtymä
- Kriittinen sairaus
- Hengitysvaikeusoireyhtymä
- Hengitysvaikeusoireyhtymä, vastasyntynyt
- Akuutti keuhkovaurio
Muut tutkimustunnusnumerot
- 2020.169.IRB1.037
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset COVID-19
-
PfizerAktiivinen, ei rekrytointiCOVID-19 | Koronavirustauti 2019 (COVID-19) | Covid-19-tartunta | Covid-19-rokotteet | SARS-CoV-2-infektio, COVID19 | COVID-19-rokotus | SARS-CoV-2-infektio, COVID-19 | COVID-19 (koronavirustauti 2019) | COVID-19 SARS-CoV-2 -infektioYhdysvallat
-
PfizerRekrytointiHengityselinten sairaudet | COVID-19 | Keuhkokuume | Keuhkosairaudet | Koronavirustauti 2019 | Koronavirustauti 2019 (COVID-19) | Covid-19-tartunta | Ylempien hengitysteiden infektiot | Hengitysteiden tulehdus | COVID-19 (koronavirustauti 2019) | COVID-19 SARS-CoV-2 -infektioBelgia
-
Shanghai Public Health Clinical CenterEi vielä rekrytointia
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Valmis
-
ModeX Therapeutics, An OPKO Health CompanyRekrytointiCOVID 19 | COVID-19 (Ennaltaehkäisy)Yhdysvallat
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RekrytointiCOVID-19 jälkeinen tila | Postaa COVID-19 | COVID-19 jälkeinen oireyhtymä | Pitkä COVID-19-oireyhtymä | COVID-19 jälkeinen tila (PCC)Saksa
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Aktiivinen, ei rekrytointiCOVID-19-testauskäyttäytyminenYhdysvallat
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRekrytointiVäsymys | COVID-19 jälkeinen oireyhtymä | COVID-19 jälkeinen tila | COVID-jälkeinen oireyhtymä | Pitkä COVID-19 | Pitkä COVID | COVID-jälkeinen tilaKanada
-
Yang I. PachankisAktiivinen, ei rekrytointiCOVID-19 hengitystieinfektio | COVID-19 stressisyndrooma | COVID-19-rokotteen haittavaikutus | COVID-19:ään liittyvä tromboembolia | COVID-19:n jälkeinen tehohoidon oireyhtymä | COVID-19:ään liittyvä aivohalvausKiina
-
Indonesia UniversityRekrytointiCOVID-19 jälkeinen oireyhtymä | Pitkä COVID | COVID-19 jälkeinen tila | COVID-jälkeinen oireyhtymä | Pitkä COVID-19Indonesia